36.4% Below Target

The consensus Wall Street price target for XP is $22, representing 36.4% upside from the current price of $16.13. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

XP has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 7 Buy/Strong Buy ratings. The consensus 12-month price target of $22 implies 36.4% upside from current levels.

With a forward P/E of 1.5553x, XP trades at a relatively low valuation. The consensus target of $22 implies 36.4% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $22 for XP, while the most conservative target is $22. The consensus of $22 represents the median expectation. Our quantitative valuation model projects a bull case target of $136 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

XP is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month XP stock forecast based on 9 Wall Street analysts shows a consensus price target of $22, with estimates ranging from $22 (bear case) to $22 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $103, with bear/bull scenarios of $65/$136.

Our quantitative valuation model calculates XP's fair value at $103 (base case), with a bear case of $65 and bull case of $136. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.

XP trades at a forward P/E ratio of 1.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 8.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on XP, with a "Buy" consensus rating and $22 price target (36.4% upside). 7 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

XP analyst price targets range from $22 to $22, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $22 consensus represents the middle ground. Our model's $65-$136 range provides an independent fundamental perspective.